Multiple Myeloma | Oncology Today with Dr Neil Love: Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Edition

published 2 days ago by Dr Neil Love

Featuring an interview with Dr Nikhil Munshi about recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma, including the following topics: Chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma (MM) — Nikhil C Munshi, MD (00:00) Case: A woman in her mid-60s with relapsed/refractory (R/R) IgG kappa MM treated with anti-BCMA CAR T-cell therapy (20:31) Case: A man in his early 60s with R/R MM with adverse cytogenetics (25:58) Case: A man in his late 70s with R/R IgG kappa MM who responds to re-treatment with CAR T-cell therapy (29:52) Future directions in anti-BCMA CAR T-cell therapies for MM; steps toward liberalizing eligibility criteria (33:08)   CME information and select publications

more episodes from Research To Practice | Oncology Videos